Pegasys
My Prescription
Payment
Select pharmacy
$1,149.19
Print or send this coupon to your phone
WalgreensPowered byAbout Pegasys
Drug Details
Peginterferon alfa-2a, also known by the brand name Pegasys, is a medication used to treat chronic hepatitis B and C infections in both children and adults. It is often used in combination with other antivirals. This drug is administered through a weekly injection under the skin. Peginterferon alfa-2a works by stimulating the body’s immune system to combat the hepatitis viruses, thereby reducing their presence in the body. While it can help manage these infections, it is not known to cure them or prevent the transmission of the virus to others. Common side effects include fatigue, headache, and fever. Patients are advised to practice safer sex, such as using latex condoms, to lower the risk of spreading the virus. Always consult healthcare professionals for guidance tailored to individual health needs.
Price history for Pegasys
1 Vial, 1ML of 180MCG/ML
Average retail price for Pegasys
Average SaveHealth price for Pegasys
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Pegasys dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1ML of 180MCG/ML | 1 Vial | $1,157.05 | $1,157.05 |
| 1ML of 180MCG/ML | 2 Vials | $2,306.09 | $1,153.05 |
| 1ML of 180MCG/ML | 3 Vials | $3,455.14 | $1,151.71 |
Pegasys FAQs
Pegasys is used for the treatment of chronic hepatitis C and chronic hepatitis B infections. It is an antiviral medication that helps to reduce the amount of virus in the body, which can improve liver function and decrease the risk of complications associated with these infections.
Yes, Pegasys (peginterferon alfa-2a) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain types of hepatitis.
Pegasys is used to treat chronic hepatitis B and chronic hepatitis C infections. It is an antiviral medication that helps to reduce the amount of virus in the body and improve liver function.
Pegasys is not a chemotherapy drug. It is a brand name for peginterferon alfa-2a, which is used primarily to treat certain types of viral infections, such as hepatitis B and C. It works by boosting the immune system to help fight the virus.
Pegasys, which contains peginterferon alfa-2a, is used to treat certain types of viral hepatitis, such as hepatitis B and C. It works by boosting the immune system to fight the virus, helping to reduce liver inflammation and damage, and potentially leading to a decrease in viral load. This can help improve liver function and slow the progression of liver disease.